TSMC Liu Deyin Talks about Stock Splitting: The Stock Price is Not That High, and There is a Tendency to Dividend More to Shareholders
我放心你带套猛
发表于 2024-6-4 12:18:29
303
0
0
On June 4th, TSMC held a shareholders' meeting to address the question of whether TSMC's stock price is considering a spin off. Chairman Liu Deyin responded that the stock price is not yet that high. On the issue of repurchasing stocks, Liu Deyin stated that the company tends to directly issue extra dividends to shareholders.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- AMD's revenue expectations did not meet the appetite of the capital market, leading to a 7.6% drop in stock price
- The stock prices of American tech giants have risen widely! Xiao Zha, Bezos, and others congratulated Trump on his victory
- Third quarter report exceeded expectations! Southeast Asian 'Little Tencent' stock price surges!
- The concept of "disinfectant grade" sanitary pads has become popular, and the stock price of DSY.US has risen by more than 10%
- What is happening behind the stock price shock of American automotive giants?
- TPL, a century old land company, has become a new member of the S&P 500 due to the surge in its stock price caused by the artificial intelligence boom
- Institution: The bull market of gold may not have ended yet
- Tesla's stock price hits a new high! Multiple investment banks have significantly raised their target prices
- DRAM demand is still in the cold winter! Micron's pessimistic outlook outlook leads to a nearly 16% drop in stock price after market hours
- At the end of the year, another innovative pharmaceutical company that has not stopped going global has won the favor of MNCs
